IPQ Inside the global regulatory dialogue

KV Resumes Drug Shipments of Its First Product After Successful FDA Inspection

Sep 17th, 2010

Please Log in to print the full article

KV Pharmaceuticals announced on September 10 that it will restart shipment of its potassium chloride capsule product Micro-K after a successful inspection in August of its St. Louis facility and a letter from FDA this...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications